Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Charles River Laboratories Intl (CRL)
NYSE:CRL
CRL Stock Chart & Stats
Day’s Range― - ―
52-Week Range$150.79 - $275.00
Previous CloseN/A
Volume179.29K
Average Volume (3M)1.11M
Market Cap
$8.30B
Enterprise Value$12.83B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)637.5
Beta1.52
Next Earnings
May 08, 2025EPS Estimate
2.13Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.25
Shares Outstanding51,141,605
10 Day Avg. Volume1,298,918
30 Day Avg. Volume1,109,834
Standard Deviation0.11
R-Squared0.43
Alpha-0.00928
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)2.07
Price to Cash Flow (P/CF)10.90
P/FCF Ratio13.70
Enterprise Value/Market Cap1.55
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit8.54
Enterprise Value/Ebitda12.95
Forecast
1Y Price Target
$177.00Price Target Upside9.09% Upside
Rating ConsensusHold
Number of Analyst Covering13
---
Bulls Say, Bears Say
Bulls Say
Cost ManagementCRL’s restructuring initiatives of $175mn in 2025 and annualized cost saving of $225mn by 2026 should help offset margin declines due to slower growth.
Supply Chain ManagementCharles River Laboratories has been sourcing new NHP farm vendors in other Southeast-Asian countries, which could help mitigate the impact of the Cambodian export suspension.
Bears Say
Supply Chain DisruptionCITES Secretariat recommends suspension of Cambodian NHP exports, which could lead to a negative reaction due to disruption in drug development, particularly in vaccines and biologics.
---
Ownership Overview
0.99% Insiders
31.65% Mutual Funds
32.89% Other Institutional Investors
9.26% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CRL FAQ
What was Charles River Laboratories Intl’s price range in the past 12 months?
Charles River Laboratories Intl lowest stock price was $150.79 and its highest was $275.00 in the past 12 months.
What is Charles River Laboratories Intl’s market cap?
Charles River Laboratories Intl’s market cap is $8.30B.
When is Charles River Laboratories Intl’s upcoming earnings report date?
Charles River Laboratories Intl’s upcoming earnings report date is May 08, 2025 which is in 75 days.
How were Charles River Laboratories Intl’s earnings last quarter?
Charles River Laboratories Intl released its earnings results on Feb 19, 2025. The company reported $2.66 earnings per share for the quarter, beating the consensus estimate of $2.528 by $0.132.
Is Charles River Laboratories Intl overvalued?
According to Wall Street analysts Charles River Laboratories Intl’s price is currently Undervalued.
Does Charles River Laboratories Intl pay dividends?
Charles River Laboratories Intl does not currently pay dividends.
What is Charles River Laboratories Intl’s EPS estimate?
Charles River Laboratories Intl’s EPS estimate is 2.13.
How many shares outstanding does Charles River Laboratories Intl have?
Charles River Laboratories Intl has 51,141,605 shares outstanding.
What happened to Charles River Laboratories Intl’s price movement after its last earnings report?
Charles River Laboratories Intl reported an EPS of $2.66 in its last earnings report, beating expectations of $2.528. Following the earnings report the stock price went up 6.872%.
Which hedge fund is a major shareholder of Charles River Laboratories Intl?
Currently, no hedge funds are holding shares in CRL
---
Charles River Labs Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$177.00 (9.09% Upside)
$177.00 (9.09% Upside)
Blogger Sentiment
Bullish
CRL Sentiment 80%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 52.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.6M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 6.2%
Last 30 Days ▲ 14.4%
Last 30 Days ▲ 14.4%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-32.09%
12-Months-Change
Fundamentals
Return on Equity
0.45%
Trailing 12-Months
Asset Growth
-8.13%
Trailing 12-Months
Company Description
Charles River Laboratories Intl
Charles River Laboratories International, Inc. is an early-stage contract research company, which provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions. It operates through the following segments: Research Models & Services, Discovery & Safety Assessment and Manufacturing Support. The Research Models & Services segment comprises of the production and sale of research models, and also offers services designed to support its client's use of research models in screening non-clinical drug candidates. The Discovery & Safety Assessment segment offers discovery and safety assessment services, both regulated and non-regulated, in which it include both in vivo and in vitro studies, supporting laboratory services, and strategic preclinical consulting and program management to support product development. The Manufacturing Support segment provides endotoxin and microbial detection, avian vaccine and biologics testing solutions. The company was founded by Henry L. Foster in 1947 and is headquartered in Wilmington, MA.
---
CRL Company Deck
---
CRL Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mixed picture with some positive aspects such as better-than-expected fourth-quarter performance, operating margin improvements, and a return to growth in biotech revenue. However, these were overshadowed by significant challenges, including projected revenue declines, particularly in the DSA segment, and difficulties in the CDMO business, leading to a cautious outlook for 2025.Read More>---
CRL Revenue Breakdown
60.53% DSA
20.48% RMS
19.00% Manufacturing
---
CRL Stock 12 Month Forecast
Average Price Target
$177.00
▲(9.09% Upside)
Technical Analysis
Best Analysts Covering CRL
1 Year
1 Year Success Rate
8/11 ratings generated profit
1 Year Average Return
+17.93%
reiterated a sell rating last month
Copying Patrick B Donnelly's trades and holding each position for 1 Year would result in 72.73% of your transactions generating a profit, with an average return of +17.93% per trade.
---